Expert Opinion on Therapeutic Targets

Stimulation of Sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats
pp. 1253-1265(13)
Authors: Bhuiyan, Md. Shenuarin; Fukunaga, Kohji

Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation
pp. 1267-1277(11)
Authors: Eltzschig, Holger K; Rivera-Nieves, Jesus; Colgan, Sean P

Translation initiation: a critical signalling node in cancer
pp. 1279-1293(15)
Authors: Robert, Francis; Pelletier, Jerry

Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease
pp. 1295-1302(8)
Authors: Rychli, Kathrin; Huber, Kurt; Wojta, Johann

Targeting SGK1 in diabetes
pp. 1303-1311(9)
Authors: Lang, Florian; Görlach, Agnes; Vallon, Volker

P2X₇-mediated chemoprevention of epithelial cancers
pp. 1313-1332(20)
Author: Gorodeski, George I

cIAP2 as a therapeutic target in colorectal cancer and other malignancies
pp. 1333-1345(13)
Authors: Miura, Koh; Karasawa, Hideaki; Sasaki, Iwao

Targeting the EGF receptor ectodomain in the context of cancer
pp. 1347-1361(15)
Authors: Huang, Lieven; De Baetselier, Patrick; Beyaert, Rudi

Role of type 3 deiodinase in cancer
pp. 1363-1373(11)
Authors: Dentice, Monica; Ambrosio, Raffaele; Salvatore, Domenico